Skip to main content

Advertisement

Stillbirths: how should its rate be reported, its disability-adjusted-life-years (DALY), and stillbirths adjusted life expectancy

Article metrics

  • 273 Accesses

Abstract

Background

A 2016 study standardized the definition of stillbirths. It estimated the rate as a proportion of total births. A 2015 paper addressed the problem of disability-adjusted life-years (DALY) for stillbirths. There has been no adjustment of life expectancy at birth to account for stillbirths.

Methods and results

We follow mathematical and computational methods, use algebra to derive relationships, and large databases. We express the rate as a proportion of live births and use this rate to adjust life expectancy at birth for stillbirths. We then use the difference between the traditional life expectancy and stillbirths adjusted life expectancy (SALE) to obtain DALY for stillbirths for 194 countries, the Millennium Development Goal regions, and income groups.

We show defining stillbirths’ rate as a proportion of live births enhances stillbirths’ importance, especially in poorer countries; negates some of its under-statement vis-a-vis neonatal mortality rate, accentuates its decrease; and permits inference about relative magnitudes of stillbirths and neonatal mortality from the two rates. Using it, we derive stillbirths adjusted life expectancy, and suggest it reflects a more complete and accurate measure of comparative life expectancies of different countries. Its difference from the traditional life expectancy is used to measure DALY for stillbirths that totals 165.3 million years worldwide.

Conclusion

Stillbirths almost equals neonatal mortality yet have not received almost equal attention. We hope highlighting them and adjusting life expectancy for it will spur health interventions so that grand convergence of health outcomes in different countries can be more rapidly achieved. We also believe SALE is a more complete and accurate measure of comparative life expectancies.

Background

Health professionals, social scientists, and international organizations have not given as much attention to stillbirths as to neonatal mortality. The first data-set for stillbirths in almost all countries became available in 2006, and was for 2000, while that on neonatal mortality have been available since 1990 [1, 2]. In 2011 stillbirth’s data for 2008 and 2009 became available; and were retrospectively estimated to 1995 for about 40% of the sample [3]. The first international goal on stillbirths (and neonatal mortality) was adopted in 2014 [4]. Using revised and updated estimates, Blencowe and colleagues estimate 2.60 million stillbirths occur yearly [5].

The stillborn rate arguably reflects a country’s quality of health care system to a greater extent than life expectancy (since the latter is affected more by smoking, diet, exercise, public sanitation and pollution) and can be an independent/supplementary health indicator. Causes of stillbirths are not fully understood. In the US, about one-fourth of stillbirths are unexplained; and stillbirths after 24 weeks of pregnancy are primarily due to pregnancy/birth related causes like placenta/ umbilical cord problems, birth defects, and infection [6]. In low income countries, where about 98% of the stillbirths globally occur and almost half of the deliveries take place at home, difficult, prolonged and obstructed labor, infections without adequate treatment, and lack of trained obstetric care (compounded by 35–45% absenteeism of health and extension workers) are the primary causes [7, 8, 9].

Earlier studies define stillbirth as fetal death in third trimester with birthweight of 1000 g or more [1, 3]. When birthweight is unavailable, 28 or more completed weeks of gestation is used (or a length of ≥35 cm if the reported gestation age is not judged reliable). Blencowe and colleagues find using birthweight as the primary criterion reduces number of stillbirths in rich countries by 15%, since fetal growth restriction causes many stillbirths [5]. They use fetal death at 28 or more completed weeks of gestation as their exclusive definition. In poor countries, famine increases stillbirths and fortifying pregnant women’s diet with protein-rich supplements reduces stillbirths by as much as 38% [10, 11, 12]. If mothers’ under-nourishment during pregnancy causes stillbirths, using birthweight lower than 1000 g as the primary criterion will undercount stillbirths in poor countries also. Accordingly, we follow fetal death at 28 or more completed gestation-weeks as our exclusive definition. Using it also excludes voluntary abortion from stillbirths, and protects women’s choice to terminate their pregnancies, since abortion after 28 weeks is rare and is mostly due to severe fetal abnormality or if pregnancy is threatening mother’s life [13, 14].

In addition, “[I] n terms of ethics the ethical concept of the fetus as a patient should replace the discourse of “unborn child” when that phrase is used normatively.” [15] “In term of science it is well recognized that between 20 and 24 weeks, it is likely that the fetus “experiences” touch and pain.” [16] “The inability to communicate does not mean that there is no pain or need of treatment.” [17] Although viability in Western countries is between 22 and 24 gestational weeks, it is higher in low income countries; and 28 weeks is chosen as a pragmatic cut-off limit to classify stillbirths.

The World Health Organization (WHO) notes the widespread perception that stillbirths are unavoidable due to congenital abnormalities [1]. It finds it to be untrue - estimating only 7.4% of stillbirths after 28 weeks are due to such factors. Its wide variation among countries (as shown following) also belies the perception of congenital abnormalities being the primarily cause.

The aim and purpose of this paper is to i) highlight the stillbirth rate that is defined consistent with neonatal mortality rate, ii) use it to adjust life expectancy at births to account for stillbirths, and iii) use the latter to obtain DALY for stillbirths. As will be clear below, the paper is a kind of review proposing new aspects for classification.

A. Methods: stillbirth rate defined consistent with neonatal mortality rate

There is no consistency among various authors on how they define the stillbirth rate. Some report it (like neonatal mortality) as a proportion of live births [18]. Others, while noting its definition varies among countries and even among states of the US, define it as a proportion of total (= still + live) births [19].

Blencowe and colleagues estimate stillbirth rates based on 2207 data points [5]. They do not break-up data into whether it reported stillbirth rate as a proportion of total or of live births. Since it is natural to define all rates (stillbirths, neonatal, infant, and child mortality) included in a study similarly, it is unlikely all 2207 data points would report stillbirth rate as a proportion of total births. Their definition is apparently based ultimately on Goldenberg and colleagues [20, 21]. Goldenberg and colleagues summarize key findings in the previous five reports in Lancet’s 2011 Stillbirth Series [22, 23, 24, 25, 26]. They define stillbirth rate as “per 1000 births,” not as “per 1000 total births,” at eight places, including in their Conclusion and Call to Action. Since the commonly accepted meaning of “births” is “live births,” by “per 1000 births,” they must mean “per 1000 live births.”

International statistical classification of diseases terms stillbirths (SB) as a proportion of live births (LB) “fetal death ratio;” and calls stillbirths as a proportion of total births (TB = SB + LB) “fetal death rate.” [27] It encourages both to be reported and requires the denominator to be always specified. Specifying the denominator in the definition itself, we term the two as still live birth rate (SLBR = SB/LB) and still total birth rate (STBR = SB/TB), respectively.

Using our nomenclature, Blencowe and colleagues provide data for STBR [5]. Mortality after live birth with 22 to 27 weeks and 6 days’ gestational age are included in the neonatal mortality rates (NMR = NM/LB) while fetal deaths with the same gestational age are excluded from STBR - since it includes stillbirths only after 28 weeks gestational age. That understates stillbirth rate’s magnitude vis-à-vis NMR. Dividing stillbirths by a bigger number (total births) and neonatal mortality by a smaller number (live births) compounds its understatement.

We can show the difference between SLBR and STBR is.

$$ SLBR- STBR= SLBR\times STBR/1000>0 $$
(1)

the two rates either both decrease or both increases, and when they decrease, the rate of decline in SLBR must be greater than that in STBR (see, Additional file 1).

(1) tells us greater the SLBR, greater is its excess over STBR. For richer countries where the stillbirth rates are low, SLBR and STBR will be quite close; but for poorer countries where they are high, the excess of SLBR over STBR will be significant.

To infer about the relative numbers of stillbirths and neonatal mortality from their relative rates requires that both adverse events be divided by the same number. That requirement is met when SLBR = SB/LB is used in the stillbirth rate to NMR ratio but not when STBR = SB/TB is used.

$$ \mathrm{Stillbirth}\ \mathrm{rate}\ \mathrm{to}\kern0.5em NMR\kern0.5em \mathrm{ratio}\ \mathrm{when}\kern0.5em SLBR\kern0.5em \mathrm{is}\ \mathrm{used}=\left( SB/ LB\right)\div \left( NM/ LB\right)= SB/ NM $$
(2)

while

$$ \mathrm{Stillbirth}\ \mathrm{rate}\ \mathrm{to}\kern0.5em NMR\kern0.5em \mathrm{ratio}\ \mathrm{when}\kern0.5em STBR\kern0.5em \mathrm{is}\ \mathrm{used}=\left( SB/ TB\right)\div \left( NM/ LB\right)=\left( SB/ NM\right)\times \left( LB/ TB\right) $$
(3)

Since (LB/TB) < 1, stillbirth rate to NMR ratio when STBR is used is smaller than when SLBR is used in the ratio instead.

Blencowe and colleagues use STBR:NMR ratio of less than 0.33 to exclude 156 data points on grounds that a ratio so low is implausible; and use this ratio of greater than 0.5 as one criterion to classify data from national routine information systems as high quality [5]. But, STBR:NMR ratio does not equal SB: NM, as Blencowe and colleagues mistakenly imply; SLBR: NMR does. This distinction needs to be recognized.

Results of defining stillbirth rate consistent with neonatal mortality rate

Table 1 compares SLBR to STBR for countries with the 10 highest stillbirth rates in 2015. Results for all countries are given in Additional file 2. They show excess of SLBR over STBR is approximately two for Pakistan and Nigeria and between one and two for 12 other countries. SLBR is higher than 30 for 14 countries (compared to 13 for STBR); its decrease is greater than that in STBR by about one percentage point for some countries. See, Additional file 2.

Table 1 Countries with ten highest stillbirth rates

Table 2 provides SLBR and SLBR:NMR ratio for 2000 and 2015 by Millennium Development Goal (MDG) regions and two income groupings: 1) high and upper mid income (richer) and 2) lower mid and low income (poorer). It also provides within region/group standard deviation and dispersion measured as standard deviation/mean (i.e., coefficient of variation), because the means are different. Table 2 shows SLBR declined for each region, signifying success. The failure is the increase in its dispersion everywhere (except one region). The increased dispersion is not accounted for anywhere in the recent stillbirth study [5].

Table 2 SLBR & SLBR: NMR by region & income-group

Table 2 shows SLBR:NMR ratio has increased in every region/income group and shows great variation both among regions and over time. E.g., in 2015, in the Caucasus and Central Asia, there were approximately 75 stillbirths for every 100 neonatal deaths; whereas in Eastern Asia, the corresponding number was approximately 130. Eastern Asia also experienced almost doubling of the SLBR:NMR ratio from 2000 to 2015. This variation across regions and over time needs further investigation.

Comparing progress by two country-income groups, the absolute reduction in poorer (i.e., lower-middle and lower income) countries’ stillborn rate from 2000 to 2015 (ignoring the negative signs) is 8.69 (= 25.28–33.97) and proportionate/percentage reduction is 25.6% (= 8.69/33.97); while the corresponding numbers for richer (i.e., high and upper-middle income) countries are 3.93 (= 7.40–11.33) and 34.7% (= 3.93/11.33), respectively. That is, the percentage reduction, or the rate of decrease, in poorer countries’ stillborn rate is smaller than that in richer countries.

The SLBR:NMR ratio for both groups increase; but that for the richer group increases by 25.6 (= 101.5–75.1) and 35.1% (= 25.6/75.1) versus 12.1 (= 97.0–84.9) and 14.3% (= 12.1/84.9) for poorer countries. That is, the percentage increase, or the rate of increase, in this ratio is greater for richer countries than for poorer countries.

Let, g (SLBR: NMR), g (SLBR) and g (NMR) represent the rates of change in SLBR: NMR, SLBR, and NMR, respectively. Then, we can show that

$$ {\displaystyle \begin{array}{l}g\ \left( SLBR: NMR\right)=g\ (SLBR)-g\ (NMR)\kern0.5em \mathrm{or}\\ {}g\ (NMR)=g\ (SLBR)-g\ \left( SLBR: NMR\right)\end{array}} $$
(4)

Using the above relationship, we can see the richer countries’ NMR also decreases by a greater percentage, disregarding the negative sign, of 69.8 (= − 34.7 - 35.1%), or at a greater rate, than for poorer countries’ 39.9 (= − 25.6 - 14.3%). The richer countries, where the 2000 rates were already much lower, achieve a greater proportionate reduction in both rates.

The Newborn Action Plan notes encouragingly that 11 poorer countries have reduced their NMR by more than 40% since 2000 [4]. By 2015, a total of 25 (not 11) such countries had passed the 40% threshold (average reduction 46.7%). At the same time, 49 richer countries had also achieved that feat (average reduction 53.5%). See, Additional file 2. Almost twice as many richer countries have achieved a greater than 40% reduction in their NMR than poorer countries; and achieved a greater reduction. The poorer countries have taken on and made some progress in an immense task. Yet, richer countries have made even more of a progress - indicating great scope of progress that is possible for poorer countries.

B. Methods: adjusting life expectancy to account for stillbirths and using it to obtain DALY for stillbirths

The traditional life expectancy at birth (LE), also called life expectancy of live births (LELB) here, includes premature births and neonates who may live no longer than an hour or a day. The stillborn can occur either antepartum (before labor or delivery) or intrapartum (during labor or delivery); and are highly sensitive to access to timely high-quality antenatal and intrapartum monitoring and care [5]. 40–45% of stillbirths, namely 1.17 million of 2.60 million total stillbirths, are intrapartum [20, 28]. This number is greater than 1.01 million live newborns who die within the first 24 h (36% of total neonatal deaths) [29]. These deaths occur rapidly, and the first minute after an infant is born—the so-called golden minute—is the crucial window for neonatal resuscitation for the 10 million non-breathing infants born annually [20]. The implications are: i) millions of non-breathing neonates are successfully resuscitated; ii) which death is stillbirth and which is neonatal can be subject to considerable error. These errors are more likely when births take place at home–as is common in rural areas of South Asia and Sub-Saharan Africa (the primary regions where most stillbirths occur) [29].

Variation in classification of neonatal mortality and stillbirths at the local level impacts the reported stillbirths and infant mortality rates [30]. Dearth of females in population cohorts since the late 1930s in China has been ascribed to female losses occurring very early in life [31]. Such female live births are simply not reported or reported as stillborn. The Helping Babies Breathe program in Tanzania reduced stillbirths by 24%; and resuscitation training in six poorer countries, reduced stillbirth rates by 31% [32, 33]. We are not proposing that population, that includes all premature live births, include the stillborn. Nevertheless, millions of stillborn, who, by definition, are after 28 weeks of gestation, are simply ignored in the life expectancy measure. We include stillbirths in vital statistics of life expectancy by adjusting it for stillbirths - calling the result stillbirths adjusted life expectancy, SALE.

Life expectancy of 1000 live births is 1000 × LELB. Dividing this product by 1000 plus the still live-birth rate, SLBR, gives us the life expectancy of total (= still + live) births, LETB, or stillbirths adjusted life expectancy, SALE.

$$ SALE= LETB=\left(1000\times LELB\right)/\left(1000+ SLBR\right) $$
(5)

For a country with no stillbirths, SLBR is zero and SALE = LE. For almost every country, stillbirths are positive, and SALE < LE. The difference between the two reflects decrease in life expectancy when stillbirths are also considered. Suppose LELB is 71 years, and SLBR is 13. Then, (5) would mean dividing 71,000 (life expectancy of 1000 live births) by 1013, rather than by 1000. The resulting number being approximately 70 years, the reduction in life expectancy by 1 year is solely due to dividing 71,000 by 1013; i.e., by including the number of stillbirths per 1000 live births in the denominator.

Now we discuss why stillbirths should be include in DALY, and how we obtain DALY for stillbirths.

DALY, while estimating life years lost due to mortality and morbidity, is also used for prioritizing health care spending [35]. Stillbirths are neither included in it nor in the global tracking mechanism such as the Global Burden of Disease estimates. Part of this reluctance may have been due to lack of reliable data on stillbirths in poorer and middle-income countries. Data on its cousin, neonatal mortality, for almost all countries has been available since 1990, while similar data for stillbirths became available only in 2006 [1, 2]. The protein-supplemental study cited above found it decreased low-weight live births by 32% also (in addition to reducing stillbirths by 38%) [12]. If stillbirths are included in DALY, nutrition and medical interventions focused on pregnant mothers may yield benefits in potential DALY reduction that are two to 10 times, and potential cost per DALY reduction one-half to one-tenth [36]. Since DALY is an important population health measure, not counting stillbirth’s reduction in DALY estimates will also yield anomalous situations where a population with a neonatal mortality reduction, whether or not achieved by moving prenatal care resources to post-natal, is considered healthier even if its incidence of late-gestation stillbirths increases.

Other substantive arguments for including stillbirths in DALY estimates are as follows. The current practice violates one of the four general principles underlying DALYs, namely “treating like outcomes as like.” [34] A 28 gestational-age fetus that is stillborn and one that dies 10 minutes after live birth are essentially like outcomes. Yet, the former is not included in DALY estimates while the latter is. We have discussed above how following fetal death at 28 or more completed gestation-weeks as our exclusive definition of stillbirths protects women’s rights and choice to terminate their pregnancies. Including stillbirths in DALY estimates will spur interventions to reduce it - interventions that predominantly focus on pregnant mother’s health, wellbeing, and prenatal and partum care - and will enhance women’s rights and condition [37].

Normally, DALY for premature mortality, or Years of Life Lost (YLL) due to premature mortality in the population, corresponds to the number of deaths multiplied by the life expectancy at the age at which death occurs [38]. This method cannot be used for stillbirths since life expectancy of stillbirths is zero. Therefore, we obtain DALY of stillbirths by multiplying decrease in life expectancy when stillbirths are also considered by the number of live births. That is,

$$ \mathrm{DALY}\ \mathrm{or}\ \mathrm{YLL}\ \mathrm{of}\ \mathrm{stillbirths}= LE- SALE=\mid SALE- LEI\mid \times LB $$
(6)

Additional file 1 shows the following:

$$ \mid SALE- LE\mid = SLBR\times LE/\left(1000+ SLBR\right)>0 $$
(7)

and greater is the SLBR and/or greater is the LE, greater is LE’s excess over SALE. Both factors in (7) are important: a) Greater the stillbirth rate, more life-years are lost due to stillbirths; b) greater the life expectancy (of live births), the more life-years are lost because a birth is still rather than live.

A recent study (as far as I know the only paper so far suggesting how DALY for stillbirths should be estimated), implicitly assuming life expectancy of a still birth equals that of a live birth, has suggested “the disvalue attached to a fetal death should gradually increase from zero, at 28 weeks gestational age, to a value equaling that of the death of a [fully developed] newborn infant, at the time of birth,” [36] That is, DALY of stillbirths should be zero, or let us say 0.01, at 28 weeks gestational age increasing to 1.00 at full-term; or increasing 100 times. Since a fetus does not develop 100 times from 28 weeks to full-term, this proposal is counter-intuitive and against medical evidence. At 28 weeks gestational age, survival without major morbidity for infants surviving to discharge is closer to one (it is 0.59) than to zero [39]. In a situation where most of the stillbirths (and pre-term neonatal mortality) take place in poor countries where the gestation age at mortality between 28 to 39 weeks are not certain, attempting precision in DALY estimation (which perforce has to make bold assumptions in valuing vastly disparate morbidity) more than in our proposal above will not be productive. In addition, this proposal suffers from its implicit assumption equating life expectancy of a still birth - that is zero - to that of a live birth.

Stillbirths (like neonatal mortality) also cause parental suffering and psychological distress and may affect parents’ life spans. Data for these effects is limited, especially in low income countries [40]. If available, it will be challenging to add it to measure like DALY of stillbirths. Nevertheless, this effect needs to be recognized.

Results: adjusting life expectancy to account for stillbirths and using it to obtain DALY for stillbirths

Table 3, Panel A summarizes results (from Additional file 3) for 10 countries with largest decrease in life expectancy due to stillbirths. Its Panel B summarizes results for countries with 10 largest DALY of stillbirths that are not included in Panel A. Decrease in life expectancy due to stillbirths is as high as approximately 3 years for Pakistan and approximately 2 (between 1.69 and 2.28) years for 17 other countries. Panel B shows India, with 39.2 million years, has the highest DALY of stillbirths. Its loss exceeds the sum of the next two countries, Nigeria and Pakistan, and is more than four times that in China. Other countries in the top 10 DALY group are Ethiopia, Bangladesh, Congo, Indonesia, Tanzania, and Egypt.

Table 3 Countries with highest i) decrease in life expectancy due to stillbirths, and ii) DALY of stillbirths

Table 4 presents results by MDG region and by two country-income groups, richer and poorer. The worldwide mean decreases in life expectancy due to considering stillbirths is 0.85 years. Regions with mean decrease significantly higher and lower than the world average are, for higher: Southern Asia (1.30 years) and Sub-Saharan Africa (1.41 years), and for lower: developed region (0.27 years) and Eastern Asia (0.54 years). The variability of this decrease, measured by standard deviation of the decrease scaled by the mean (since the means are different), among countries in a region is the lowest in the Caucasus and Central Asia (25.8) and Sub-Saharan Africa (30.8), and highest in Southern Asia (60.2) and Eastern Asia (57.9) -suggesting efforts to reduce it may be more successful in the latter two regions. The worldwide DALY = years of lost life due to stillbirths was 165.3 million years in 2015. Of this, 122.3 million (74%) are in Southern Asia and Sub-Saharan Africa. By income, 138 million (83.5%) of DALY due to stillbirths are in poorer countries.

Table 4 Stillbirth-caused decrease in life expectancy and DALY or years of life lost by region & income-group

The gap between average life expectancies between the developed region (rich) and Sub Saharan Africa (poor) is 18.98 years (= 79.31–60.33) for LE; and 20.12 years for SALE (= 79.04–58.92). We can describe the health convergence objective in two alternative ways: i) poor countries need to increase their life expectancy of live births by approximately 19 years and decrease their still live-birth rate from 29.50 to 3.44 (see, Table 2); or ii) they need to increase their stillbirths adjusted life expectancy by approximately 20.1 years. In some sense, the second may be preferred since it directly incorporates the stillbirth objective in the life expectancy measure. Because many neonatal deaths, 40% of which occur on the first day of life, are misreported as stillbirths, incorporating stillbirths may also reflect a more accurate (and complete) measure of life expectancy.

Conclusion

Main findings

Stillbirths almost equals neonatal mortality yet have not received almost equal attention. Defining stillbirths’ rate as a proportion of live births enhances stillbirths’ importance, especially in poorer countries; and negates some of its under-statement vis-a-vis neonatal mortality rate. We employ this definition to adjust life expectancy for stillbirths; and propose the latter to get stillbirths’ DALY that equal 165.3 million years.

Meaning of the findings, research implications

Stillbirth rate arguably reflects a country’s quality of health care system to a greater extent than life expectancy; and stillbirths adjusted life expectancy reflects a more complete and accurate measure of comparative life expectancies. Including it in DALY will lead to better priorities in health care spending. Highlighting stillbirths and adjusting life expectancy for it will spur research on stillbirths whose causes are not well understood.

Clinical and health implications

Some key interventions such as syphilis treatment in pregnancy, fetal heart monitoring, and labor surveillance could be crucial in preventing intrapartum stillbirths [3]. In low income countries, only a minority of deliveries occur in health facilities or with the assistance of a trained personnel. This is due to both inadequate resources and absenteeism of health workers [9, 10]. The implication is need for both more resources and better governance. Further, resuscitation training of health care workers in poorer countries is sorely needed.

Strength and weaknesses

The paper’s strengths are a) highlighting that having different divisors for stillbirths and neonatal mortality rates may give inconsistent results. and b) traditional life expectancy suffers from the limitation that what is stillbirth and what is a live birth is subject to considerable error. Its weakness is that data on stillbirths are not estimated by UN Inter-agency Group for Child Mortality Estimation, childmortality.org. If the latter estimates stillbirths while appraising its neonatal mortality numbers, the estimates of both are likely to improve.

In 2016, the definition of stillbirths was standardized to mean fetal loss after 28 weeks of gestation [5]. It defined stillbirth rate as a proportion of total (still + live) births. We are proposing it be called still total birth rate, and what international statistical classification of diseases terms “fetal death ratio,” (stillbirths as a proportion of live births) be called still live birth rate [27]. The latter accentuates its decline and makes the stillbirth rate comparable to NMR. Using it, we derive stillbirths adjusted life expectancy. Its difference from the traditional life expectancy reflects DALY for stillbirths that totals 165.3 million years worldwide.

There has been a call for better prenatal, natal, and neonatal health monitoring and improved data definitions/methods with consistent metrics [21]. There are triple benefits from such attention: benefits i) for stillbirths, ii) for neonatal deaths, and iii) for mothers; life complications and disability may also be reduced [21]. Stillbirths in poorer countries are another dimension of health that needs to be addressed when seeking, hopefully rapid, grand convergence to health outcomes in richer countries. A stillbirth-incorporated definition of the widely used life expectancy measure will attract more attention to stillbirth. Life expectancy at birth ignores morbidity and is a “very imperfect measure of health.” [41] Adjusting it for stillbirths will also remove some of its imperfections.

Availability of data and materials

The datasets analyzed during the current study are available (and no (administrative) permission is required to use/reuse them) in the.

a) Supplementary Material to Blencowe et al. (2016) Blencowe H, Cousens S, Jassir F-B, et al. (2016) National, regional, and worldwide estimates of stillborn rates in 2015, with trends from 2000: a systematic analysis. Lancet Globl Health 4: e98–108.

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(15)00275-2/fulltext#seccestitle190.

b) World Bank. World Development Indicators. The World Bank. Washington, D.C.

https://data.worldbank.org/indicator/SP.DYN.IMRT.IN

https://data.worldbank.org/indicator/sp.dyn.le00.in

c) UN Inter-agency Group for Child Mortality Estimation (UNICEF, WHO, World Bank, UN DESA Population Division) - for neonatal mortality rate and numbers for Cook Islands.

childmortality.org

d) U.S. Census Bureau: International Database - for life expectancy numbers for Marshall Islands and Palau.

https://www.census.gov/programs-surveys/international-programs/about/idb.html

Abbreviations

DALY:

Disability-adjusted life-years

LB:

Number of live births

LE = LELB:

Life expectancy of live births

LETB:

Life expectancy of total (= still + live) births = SALE

MDG:

Millennium development goals

NM:

Number of neonatal mortalities

NMR:

Neonatal mortality rate

SALE:

Stillbirths adjusted life expectancy

SB:

Number of still births

SLBR:

Still live birth rate (= SB/LB)

STBR:

Still total (= still + live) birth rate (= SB/TB)

TB:

Number of total (= still + live) births

YLL:

Years of life lost

References

  1. 1.

    WHO. Neonatal and perinatal mortality, Country, regional and global estimates. Geneva: World Health Organization; 2006.

  2. 2.

    Child Mortality Estimates, http://www.childmortality.org. Accessed 12 Nov 2018

  3. 3.

    Cousens S, Blencowe H, Stanton C, Chou D, Ahmed S, et al. National, regional, and worldwide estimates of stillborn rates in 2009 with trends since 1995: a systematic analysis. Lancet. 2011;377:1319–30.

  4. 4.

    WHO, UNICEF. Every Newborn: An action plan to end preventable deaths. Geneva: World Health Organization; 2014.

  5. 5.

    Blencowe H, Cousens S, Jassir FB, Say L, Chou D, et al. National, regional, and worldwide estimates of stillborn rates in 2015, with trends from 2000: a systematic analysis. Lancet Globl Health. 2016;4:e98–108.

  6. 6.

    The Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA. 2011;306(22):2459–68.

  7. 7.

    McClure EM, Goldenberg RJ. Stillbirth in developing countries: a review of causes, risk factors and prevention strategies. J Matern Fetal Neonatal Med. 2009;22(3):183–90.

  8. 8.

    Banerjee A, Deaton A, Duflo E. Wealth, health, and health services in rural Rajasthan. Am Econ Rev. 2004;94(2):326–30.

  9. 9.

    Chaudhury N, Hammer J, Kremer M, Muralidharan K, Rogers FH. Missing in action: teacher and health worker absence in developing countries. J Econ Perspect. 2006;20(1):91–116.

  10. 10.

    Hernandez-Julian R, Mansour H, Peters C. The effects of intrauterine malnutrition on birth and fertility outcomes: evidence from the 1974 Bangladesh famine. Demography. 2014;51(5):1775–96.

  11. 11.

    Cai Y, Wang F. Famine, social disruption, and involuntary fetal loss: evidence from Chinese survey data. Demography. 2005;42(2):301–22.

  12. 12.

    Imdad A, Bhutta Z. Maternal nutrition and birth outcomes: effect of balanced protein-energy supplementation. Pediatr Perinat Epidemiol. 2012;26(Suppl. 1):178–90.

  13. 13.

    Jatlaoui TC, Ewing A, Mandel MG, Simmons KB, Suchdev DB, et al. Abortion surveillance — United States, 2013. MMWR CDC Surveill Summ. 2016;65(12):1–44.

  14. 14.

    Guttmacher Institute. The limitations of U.S. statistics on abortion. January 1, 1997.

  15. 15.

    McCullough LB, Chervenak FA. A critical analysis of the concept and discourse of 'unborn child'. Am J Bioeth. 2008;8(7):34–9.

  16. 16.

    Lloyd-Thomas AR, Fitzgerald M. Do fetuses feel pain? Reflex responses do not necessarily signify pain. BMJ. 1996;313(7060):797–8.

  17. 17.

    Anand KJ, Aranda JV, Berde CB, Buckman S, Capparelli EV, et al. Summary proceedings from the neonatal pain-control group. Pediatrics. 2006;117(3 Pt2):S9–22.

  18. 18.

    Nielsen BB, Liljestrand J, Hedegaard M, Thilsted SH, Joseph A. Reproductive pattern, perinatal mortality, and sex preference in rural Tamil Nadu, South India: community based, cross sectional study. BMJ. 1997;314:1521–4.

  19. 19.

    Woods R, editor. Long-term trends in fetal mortality: implications for developing countries. Bull World Health Organ. 2008;86(6):417–96.

  20. 20.

    Lawn JE, Blencowe H, Oza S, You D, Lee ACC, et al. Every newborn: Progress, priorities, and potential beyond survival. Lancet. 2014;384:189–205.

  21. 21.

    Goldenberg RL, McClure EM, Bhutta ZA, Belizan JM, Reddy UM, et al. And the Lancet’s stillbirths series steering committee. Stillbirths: the vision for 2020. Lancet. 2011;377:1798–805.

  22. 22.

    Lawn JE, Blencowe H, Pattinson R, Cousens S, Kumar R, et al for The Lancet’s Stillbirths Series steering committee. Stillbirths: Where? When? Why? How to make the data count? Lancet. Published online April 14, 2011; doi:https://doi.org/10.1016/S0140-6736(10)62187.

  23. 23.

    Frøen JF, Cacciatore J, McClure EM, Kuti O, Jokhio AH, et al for the Lancet’s stillbirths series steering committee. Stillbirths: why they matter. Lancet. Published online April 14, 2011; doi:https://doi.org/10.1016/S0140-6736(10)62232–62235.

  24. 24.

    Bhutta ZA, Yakoob MY, Lawn JE, Rizvi A, Friberg IK, et al, For the Lancet’s stillbirths series steering committee. Stillbirths: what difference can we make and at what cost? Lancet. Published online April 14, 2011; doi:https://doi.org/10.1016/S0140-6736(10)62269-6.

  25. 25.

    Pattinson R, Kerber K, Buchmann E, Friberg IK, Belizan M, et al. for the Lancet’s stillbirths series steering committee. Stillbirths: how can health systems deliver for mothers and babies? Lancet. Published online April 14, 2011; doi:https://doi.org/10.1016/S0140-6736(10)62306-9.

  26. 26.

    Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, et al. for The Lancet’s Stillbirths Series steering committee. Stillbirths: the way forward in high-income countries. Lancet. Published online April 14, 2011; doi:https://doi.org/10.1016/S0140-6736(11)60064-0.

  27. 27.

    WHO. International statistical classification of diseases and related health problems, 10th revision, Vol. 2, instruction manual. Geneva, 1993, Fifth Edition 2016.

  28. 28.

    Save the Children. Surviving the first day. State of the world’s mothers. Save the Children, 2013. ISBN 1-888393-26-2.

  29. 29.

    Lawn JE, Kinney MV, Black RE, Pitt C, Cousens S, et al. Newborn survival: a multi-country analysis of a decade of change. Health Policy Plan. 2012;27(suppl 3):iii6–28.

  30. 30.

    Woods CR, Davis DW, Duncan SD, Myers JA, O’Shea TM, et al. Variation in classification of live birth with newborn period death versus fetal death at the local level may impact reported infant mortality rate. BMC Pediatr. 2014;14:108.

  31. 31.

    Coale AJ, Banister J. Five decades of missing females in China. Demography. 1994;31(3):459–79.

  32. 32.

    Msemo G, Massawe A, Mmbando D, Rusibamavila N, Manji K, et al. Newborn mortality and fresh stillbirth rates in Tanzania after helping babies breathe training. Pediatrics. 2013;131(2):e353–60.

  33. 33.

    Carlo WA, Goudar SS, Jehan I, Chomba E, Tshefu A, et al. Newborn-care training and perinatal mortality in developing countries. N England J Med. 2010;362(7):614–23.

  34. 34.

    Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press; 1996.

  35. 35.

    Bobadilla J, Cowley P, Musgrove P, Saxenian H. Design, content, and packaging of an essential national package of health services. Bull World Health Organ. 1994;72:653–62.

  36. 36.

    Phillips J, Millum J. Valuing stillbirths. Bioethics. 2015;29(6):413–23.

  37. 37.

    Barros FC, Bhutta ZA, Batra M, Hansen TN, Victoria CG, et al. Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions. BMC Pregnancy Childbirth. 2010;10(Suppl 1):s3.

  38. 38.

    WHO Metrics: Disability-Adjusted Life Year (DALY), http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/, downloaded November 12, 2018

  39. 39.

    Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–51.

  40. 40.

    Heazell AE, Siassakos D, Blencowe H, Burden C, Butta ZA, et al. Stillbirths: economic and psychosocial consequences. Lancet. 2016;387:604–16.

  41. 41.

    Jones CI, Klenow PJ. Beyond GDP? Welfare across countries and time. Am Econ Rev. 2016;106(9):2426–57.

Download references

Acknowledgements

Not applicable

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

CK is the sole author of this article, he alone is responsible for the content and the views expressed in this article. The author read and approved the final manuscript.

Correspondence to Chander Kant.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The author declares that he/she has no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional files

Additional file 1:

Mathematical derivations; format. (PDF 428 kb)

Additional file 2:

Still live-birth and total-birth rates, and SLBR:NMR ratio, 2000 and 2015, by country; format. (PDF 575 kb)

Additional file 3:

Life expectancy & stillbirths adjusted life expectancy, 2000 & 2015, and i) decrease in life expectancy due to stillbirths, and ii) DALY = YLL of stillbirths, 2015, by country; format. (PDF 451 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Keywords

  • Different measures of stillbirth rates
  • Years of life lost due to stillbirths
  • A more complete measure of life expectancy
  • Importance of stillbirths in poorer countries